Johnson Johnson Profile

146.91
USD 0.01  0.0068%
99%
146.98
39%
147.65

Johnson Johnson exotic insider transaction detected

Johnson Johnson insider trading alert for general transaction of common stock by Alex Gorsky, Chairman CEO, on January 2, 2018. This event was filed by Johnson Johnson with SEC on 2016-02-10. Statement of changes in beneficial ownership - SEC Form 4. Alex Gorsky is currently serves as chairman, ceo, chairman of executive committee and chairman of fin. committee of Johnson Johnson [view details]   

Johnson Johnson Summary

Johnson & Johnson are known for their many different products. Odds are if you search your bathroom you will find multiple products made by this company. Solid and sound, the company has been upgraded by Wells Fargo, which is positive news for price movement. As well as that, the company has acquired the company Actelion, which operates in the biotech industry. [more]
Johnson Johnson (JNJ) is traded on New York Stock Exchange in USA. It is located in NEW JERSEY, U.S.A and employs 127,100 people. Johnson Johnson is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mega-Cap' category with total capitalization of 391.59 B. Johnson Johnson runs under Healthcare sector within Healthcare Products industry. This company has 2.69 B outstanding shares of which 13.21 M shares are currently shorted by investors with about 2.43 days to cover shorted positions. JOHNSON AND JOHNS has about 16.28 B in cash with 21.6 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.06.
Check Johnson Johnson Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Selected Johnson Johnson Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Johnson Johnson Against Markets

Risk Adjusted
Performance Score (0 to 100)
26 
Chance of
Financial Distress (0 to 100%)
< 6% 
Equity ratings for Johnson Johnson are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Johnson Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various solutions in the health care field worldwide. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameJohnson Johnson
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
Specialization
Healthcare, Healthcare Products
InstrumentUSA Stock Stocks Directory
RegionNorth America
LocationNEW JERSEY, U.S.A
Business AddressOne Johnson and Johnson Plaza, New Brunswick, NJ 08933, United States
Foreign Associates
ExchangeNew York Stock Exchange
CIK Number00200406.0
ISINUS4781601046
CUSIP478160104
SectorHealthcare
IndustryHealthcare Products
BenchmarkDOW
Websitewww.jnj.com
Contact Number732 214 0332
CurrencyUSD - US Dollar

Current Sentiment - JNJ

Johnson Johnson Investor Sentiment
Predominant part of Macroaxis users are currently bullish on Johnson Johnson. What is your judgment towards investing in Johnson Johnson? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip  Hide

Recommendations

Johnson Johnson Analyst Recommendations
Target PriceAdvice# of Analysts
123.93Hold15Odds
Johnson Johnson current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Johnson Johnson Analyst Advice  

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Earnings

Johnson Johnson Earnings Estimates
EPSEstimate Date
Quarterly Estimate1.76April 18, 2017
Johnson Johnson normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate